Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001567619-22-006231 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | MEDP | Troendle August J. | CEO, Dir, 10% | M - OptEx | $90.65 | +100.0K | 806.6K | +14% | +$9.06M |
| D | 2022-03-03 | 2022-03-01 | MEDP | Troendle August J. | CEO, Dir, 10% | M - OptEx | $0.00 | -100.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | M | A | 100,000 | $90.65 | 806,643 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2022-03-01 | M | D | 100,000 | $0.00 | 0 | D | $90.65 · — to 2024-08-05 | 100,000 Common Stock | (F2) The option vested on August 5, 2019. |